According to a new market report published by Transparency Market Research "Insulin Market - Global and China Scenario, Trends, Industry Analysis, Size, Share and Forecast, 2011 - 2018" the global insulin market was worth USD 12,476.3 million in 2011 and is expected to reach USD 32,346.7 million in 2018, growing at a CAGR of 12% from 2011 to 2018. In the global market, China is expected to increase its share in the global insulin market to 10.2% by 2018. The global insulin market is driven by rise in diabetic population worldwide. The world diabetes population was estimated at 366 million in the year 2011, and is expected to reach 552 million in 2030. It is estimated that diabetes accounts for 4.6 million deaths, with cases of people dying due to lack of insulin and not even being diagnosed. Browse the full Insulin Market Report at http://www.transparencymarketresearch.com/insulin-market.html

1. USD 4595
USD 7595
Transparency Market
Research
Insulin Market - Global And
China Industry Analysis,
Size, Share, Growth, And
Forecast 2011
- 2018
Single User License:
Multi User License:
Corporate User License:
USD 10595
Published Date
19-Sept-2012
Buy Now
105 Page Report
Request Sample
Press Release
Insulin Market Expected to Reach USD 32,346.7 Million in 2018
- Transparency Market Research
Transparency Market Research
State Tower,
90, State Street, Suite 700.
Albany, NY 12207
United States
www.transparencymarketresearch.com
sales@transparencymarketresearch.com

2. REPORT DESCRIPTION
According to a new market report published by Transparency Market Research "Insulin Market - Global
and China Scenario, Trends, Industry Analysis, Size, Share and Forecast, 2011 - 2018" the global insulin
market was worth USD 12,476.3 million in 2011 and is expected to reach USD 32,346.7 million in 2018,
growing at a CAGR of 12% from 2011 to 2018. In the global market, China is expected to increase its
share in the global insulin market to 10.2% by 2018.
The global insulin market is driven by rise in diabetic population worldwide. The world diabetes population
was estimated at 366 million in the year 2011, and is expected to reach 552 million in 2030. It is
estimated that diabetes accounts for 4.6 million deaths, with cases of people dying due to lack of insulin
and not even being diagnosed.
Browse the full Insulin Market Report at http://www.transparencymarketresearch.com/insulin-
market.html
This however, presents a huge supply demand deficit for insulin, with high growth potential in developing
markets. The factors contributing to the insulin market growth also includes increase in global expenditure
on healthcare, strong distribution network, and high scope in developing economies such as China and
India.
It is estimated that worldwide, by year 2030, one in ten people will suffer from diabetes, giving rise to
huge demand for insulin. China, being the most populous nation in the world, accounts for the largest
share of the global diabetic population and eventually turns out as the most lucrative market for insulin
manufacturers.
Get Free Sample Report at
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=259
The China insulin market is projected to grow at a CAGR twice that of the global insulin market. It was
estimated at USD 723.8 million in 2011, and is projected to reach USD 3,299.1 million in the year 2018,
growing at a CAGR of 24.6%. Currently, China accounts for 6.1% of the global insulin market in terms of
Transparency Market Research
2
Insulin Market

3. volume, which was estimated at 22.4 tMU in 2011. The global insulin market by volume is projected to
grow at a CAGR of 7.9% from 2012 - 2018.
The global insulin market has continuously witnessed new advanced product types being introduced in the
market by insulin manufacturers. The recent product type is modern insulin, which is a genetically
engineered version of human insulin, and has been selectively modified to counter the issues associated
with human insulin. Currently, modern insulin accounts for more than 76% of the global insulin market.
To meet the rising demand, global insulin manufacturers are not only augmenting existing production
facilities, but also expanding their global presence to meet the supply demand gap. Leading insulin
manufacturers are now focusing on reinforcing their market leadership in China. It includes key global and
China insulin market players such as Novo Nordisk, Sanofi-Aventis, and Eli-Lilly. Together they account for
more than 90% of the global insulin market share.
Browse all Pharmaceutical Research Report at
http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
This research is specially designed to estimate and analyze the demand and performance of the global and
China insulin market in the current market scenario. This research provides in-depth analysis of insulin
manufacturers, product sales, trend analysis by segments, and demand by geography. The report covers
all the major product segments of the global and China insulin market and provides in-depth analysis,
historical data and statistically refined forecast for the segments covered.
TABLE OF CONTENT
CHAPTER 1 INTRODUCTION
1.1 REPORT DESCRIPTION
1.2 SCOPE OF THE REPORT
1.3 METHODOLOGY
Transparency Market Research
3
Insulin Market

4. CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 GLOBAL INSULIN MARKET, 2011 - 2018
3.1 MARKET OVERVIEW
3.2 GLOBAL INSULIN MARKET SIZE REVENUE, 2011 - 2018 (USD MILLION)
3.3 GLOBAL INSULIN MARKET SIZE VOLUME, 2011 - 2018 (TMU)
3.4 GLOBAL INSULIN DEMAND GROWTH TREND, 2011 - 2018 (%)
3.5 GLOBAL INSULIN MARKET SHARE, 2011
3.6 MACROECONOMIC FACTORS
3.6.1 GLOBAL POPULATION GROWTH, 2011 - 2018 (MILLION)
3.6.2 GLOBAL DIABETES POPULATION GROWTH, 2011 – 2030 (27 – 79 YEARS)
3.6.3 GLOBAL DIABETES PREVALANCE RATES BY AGE GROUP, 2011 – 2030
3.6.4 GLOBAL GROSS DOMESTIC PRODUCT (GDP) PER CAPITA, 2011 - 2018 (USD)
3.7 INSULIN MARKET SEGMENTATION
3.8 PRICE TRENDS
3.8.1 GLOBAL PRICE TRENDS
3.8.1.1 PRICE TRENDS – BY ACTION
3.8.1.2 PRICE TRENDS – BY TYPE
3.8.1.3 PRICE TRENDS – BY PURCHASE TYPE
Browse the full Insulin Market Report at http://www.transparencymarketresearch.com/insulin-
market.html
Transparency Market Research
4
Insulin Market

5. CHAPTER 4 CHINA INSULIN MARKET, 2011 - 2018
4.1 MARKET OVERVIEW
4.2 CHINA INSULIN MARKET SIZE REVENUE, 2011 - 2018 (USD MILLION)
4.3 CHINA INSULIN MARKET SIZE VOLUME, 2011 - 2018 (TMU)
4.4 DEMAND GROWTH TREND FOR INSULIN IN CHINA, 2011 - 2018 (%)
4.5 CHINESE INSULIN MARKET SHARE, 2011
4.6 MACROECONOMIC FACTORS
4.6.1 POPULATION GROWTH OF CHINA, 2010 - 2018 (MILLION)
4.6.2 CHINESE DIABETES POPULATION GROWTH, 2011 - 2030(27 – 79 YEARS)
4.6.3 CHINA DIABETES PREVALANCE RATES BY AGE GROUP, 2011 – 2030
4.6.4 GROSS DOMESTIC PRODUCT PER CAPITA OF CHINA, 2011 - 2018 (USD)
4.6.5 PRICE TRENDS
4.6.5.1 PRICE TRENDS – BY ACTION
4.6.5.2 PRICE TRENDS – BY TYPE
4.6.5.3 PRICE TRENDS – BY PURCHASE TYPE
CHAPTER 5 GLOBAL INSULIN MARKET REVENUE AND VOLUME – BY SEGMENT
5.1 GLOBAL SHORT ACTING INSULIN MARKET REVENUE, 2011 – 2018 (USD)
5.2 GLOBAL SHORT ACTING INSULIN MARKET VOLUME, 2011 - 2018 (TMU)
5.3 GLOBAL PRE-MIXES INSULIN MARKET REVENUE, 2011 – 2018 (USD)
Transparency Market Research
5
Insulin Market

6. 5.4 GLOBAL PRE-MIXES INSULIN MARKET VOLUME, 2011 - 2018 (TMU)
5.5 GLOBAL LONG ACTING INSULIN MARKET REVENUE, 2011 – 2018 (USD)
5.6 GLOBAL LONG ACTING INSULIN MARKET VOLUME, 2011 - 2018 (TMU)
5.7 GLOBAL HUMAN INSULIN MARKET REVENUE, 2011 – 2018 (USD)
5.8 GLOBAL HUMAN INSULIN MARKET VOLUME, 2011 - 2018 (TMU)
5.9 GLOBAL MODERN INSULIN MARKET REVENUE, 2011 – 2018 (USD)
5.10 GLOBAL MODERN INSULIN MARKET VOLUME, 2011 - 2018 (TMU)
5.11 GLOBAL ANIMAL INSULIN MARKET REVENUE, 2011 – 2018 (USD)
5.12 GLOBAL ANIMAL INSULIN MARKET VOLUME, 2011 - 2018 (TMU)
5.13 GLOBAL DOSAGE PURCHASE INSULIN MARKET REVENUE, 2011 – 2018 (USD)
5.14 GLOBAL DOSAGE PURCHASE INSULIN MARKET VOLUME, 2011 - 2018 (TMU)
5.15 GLOBAL BULK PURCHASE INSULIN MARKET REVENUE, 2011 – 2018 (USD)
5.16 GLOBAL BULK PURCHASE INSULIN MARKET VOLUME, 2011 - 2018 (TMU)
Browse the full Insulin Market Report at http://www.transparencymarketresearch.com/insulin-
market.html
CHAPTER 6 CHINA INSULIN MARKET REVENUE AND VOLUME – BY SEGMENT
6.1 CHINA SHORT ACTING INSULIN MARKET REVENUE, 2011 – 2018 (USD)
6.2 CHINA SHORT ACTING INSULIN MARKET VOLUME, 2011 - 2018 (TMU)
6.3 CHINA PRE-MIXES INSULIN MARKET REVENUE, 2011 – 2018 (USD)
Transparency Market Research
6
Insulin Market

7. 6.4 CHINA PRE-MIXESINSULIN MARKET VOLUME, 2011 - 2018 (TMU)
6.5 CHINA LONG ACTING INSULIN MARKET REVENUE, 2011 – 2018 (USD)
6.6 CHINA LONG ACTING INSULIN MARKET VOLUME, 2011 - 2018 (TMU)
6.7 CHINA HUMAN INSULIN MARKET REVENUE, 2011 – 2018 (USD MILLION)
6.8 CHINA HUMAN INSULIN MARKET VOLUME, 2011 - 2018 (TMU)
6.9 CHINA MODERN INSULIN MARKET REVENUE, 2011 – 2018 (USD)
6.10 CHINA MODERN INSULIN MARKET VOLUME, 2011 - 2018 (TMU)
6.11 CHINA ANIMAL INSULIN MARKET REVENUE, 2011 – 2018 (USD)
6.12 CHINA ANIMAL INSULIN MARKET VOLUME, 2011 - 2018 (TMU)
6.13 CHINA DOSAGE PURCHASE INSULIN MARKET REVENUE, 2011 – 2018 (USD)
6.14 CHINA DOSAGE PURCHASE INSULIN MARKET VOLUME, 2011 - 2018 (TMU)
6.15 CHINA BULK PURCHASE INSULIN MARKET REVENUE, 2011 – 2018 (USD)
6.16 CHINA BULK PURCHASE INSULIN MARKET VOLUME, 2011 - 2018 (TMU)
CHAPTER 7 COMPETITIVE LANDSCAPE
7.1 COMPETITIVE STRATEGY BY KEY PLAYERS
7.2 CHINESE INSULIN MARKET SHARE BY KEY PLAYERS, 2009 – 2011
CHAPTER 8 COMPANY PROFILE
8.1 NOVO NORDIS
8.1.1 COMPANY OVERVIEW
Transparency Market Research
7
Insulin Market

8. 8.1.2 FINANCIAL OVERVIEW
8.1.3 SEGMENT OVERVIEW
8.1.4 EMPLOYEE STRENGTH
8.1.5 GEOGRAPHIC OVERVIEW
8.1.6 GROWTH STRATEGY
8.1.7 RECENT DEVELOPMENTS
Browse the full Insulin Market Report at http://www.transparencymarketresearch.com/insulin-
market.html
8.2 ELI LILLY AND COMPANY
8.2.1 COMPANY OVERVIEW
8.2.2 FINANCIAL OVERVIEW
8.2.3 SEGMENT OVERVIEW
8.2.3.1 Neuroscience products
8.2.3.2 Endocrinology products
8.2.3.3 Oncology products
8.2.3.4 Cardiovascular products
8.2.4 EMPLOYEE STRENGTH
8.2.5 GEOGRAPHIC SEGMENT
8.2.6 GROWTH STRATEGY
Transparency Market Research
8
Insulin Market

9. 8.2.7 RECENT DEVELOPMENTS
8.3 SANOFI-AVENTIS
8.3.1 KEY PRODUCTS
8.3.2 BRANDS
8.3.3 REVENUE CONTRIBUTION BY GEOGRAPHY
8.3.4 REVENUE TREND
8.3.5 RECENT DEALS
About Us
Transparency Market Research is a market intelligence company providing global business information
reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-
looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use
proprietary data sources and various tools and techniques to gather, and analyze information. Our
business offerings represent the latest and the most reliable information indispensable for businesses to
sustain a competitive edge.
Contact:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
Blog: http://tmrresearch.wordpress.com/
Transparency Market Research
9
Insulin Market